FRANK KARBE - 18 Dec 2023 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Leslie Miller, Attorney-in-fact
Issuer symbol
BTTX on OTC
Transactions as of
18 Dec 2023
Net transactions value
$0
Form type
4
Filing time
20 Dec 2023, 17:13:55 UTC
Previous filing
31 Jul 2023
Next filing
24 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Award $0 +62,500 +13% $0.000000 526,516 18 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting person was awarded 62,500 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
F2 Includes 34,587 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2023.